ALEC’s Campaign to Legislate Corporate Immunity
May 30, 2012, 9:49 PM
Despite recent backlash and intense consumer pressure on corporations to drop sponsorship of the shadowy front group, the American Legislative Exchange Council (ALEC), many corporations are standing by ALEC. Corporations have used ALEC’s Civil Justice Task Force to get a wide swath of state laws enacted to grant corporate immunity when products injure or even kill consumers. For decades, corporate immunity has been ALEC’s specialty.
Read More
Patients Injured by Generic Drugs Get a Glimmer of Hope from Court
May 18, 2012, 1:29 PM
Even though generic drug makers claim a recent Supreme Court decision gave them immunity from ALL lawsuits, some victims harmed by generic drugs may have a glimmer of hope. The First Circuit ruled some claims can go forward against the generic maker and upheld a jury award in a case called Bartlett v. Mutual Pharmaceutical Co. This decision comes after last year’s SCOTUS Pliva v. Mensing decision that granted generic drug makers immunity from most lawsuits.
Read More
IOM finds FDA Drug Monitoring Deficiencies
May 15, 2012, 1:06 PM
The Institute of Medicine (IOM) released a report earlier this month recommending that the U.S. Food and Drug Administration (FDA) review drugs on a regular basis for as long as they are on the market in order to catch any new safety issues. The IOM also recommended that the FDA create a comprehensive, publicly available document that reflects risks as they crop up throughout the "lifecycle" of the drug. This report...
Read More